Atlas Trials

Effect of Continuous GHRP-3 Infusion at on GH-IGF-I System, Blood Pressure, Glucose, and Insulin Resistance

Clinical trial NCT00846872 · WITHDRAWN

Trial details

NCT number
NCT00846872
Sponsor
Tulane University Health Sciences Center
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Insulin ResistanceEndothelial Dysfunction
Start date
2008-07-01
Primary completion
2012-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.